Fosamax

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Nahla A Belal Data Mining Model to Predict Fosamax Adverse Events Fosamax (Alendronate) is an approved drug widely prescribed for… (More)
Is this relevant?
2012
2012
BACKGROUND Renal transplant patients often have severe bone and mineral deficiencies. While the clinical effects of… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2012
2012
Gastrointestinal side-effects of alendronate (ALN) are believed to be associated with oesophageal lodging of tablets and perhaps… (More)
Is this relevant?
2010
2010
A 90-year old woman attended a department of Oral and Maxillofacial Surgery with a tongue that had been painful for at least 3… (More)
Is this relevant?
2007
2007
PURPOSE To assess the risk and time course of oral bisphosphonate-induced osteonecrosis of the jaws. MATERIALS AND METHODS… (More)
  • table 1
  • figure 1
  • figure 3
  • figure 2
  • figure 4
Is this relevant?
Review
2005
Review
2005
PURPOSE Bisphosphonates inhibit bone resorption and thus bone renewal by suppressing the recruitment and activity of osteoclasts… (More)
  • figure 4
Is this relevant?
2003
2003
OBJECTIVE Poor quality has been reported for some generics and other copies of original products. We performed a pilot study to… (More)
Is this relevant?
2003
2003
Alendronate sodium is a potent inhibitor of bone resorption which has been effectively used to control osteolysis, and to treat… (More)
Is this relevant?
2000
2000
We measured bone mineral density (BMD), four markers of bone formation [bone alkaline phosphatase (bAP), osteocalcin (Oc), N- and… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
1998
1998
OBJECTIVES To evaluate effects on bone mineral density (BMD), safety, and tolerability of a single daily dose of alendronate (10… (More)
Is this relevant?